This webinar will focus on the critical chemistry, manufacturing and controls (CMC) elements of a product’s life cycle and how Lonza applies its knowledge and experience to provide the regulatory submissions support and strategy necessary for a successful biologics licence application (BLA). You can also learn how Lonza tailors and shortens a development timeline should a product be approved for one of the US Food and Drug Administration's expedited pathways to market.
Latest content